Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-021950
Filing Date
2024-08-21
Accepted
2024-08-21 20:43:48
Documents
1
Period of Report
2024-08-13

Document Format Files

Seq Description Document Type Size
1 form4-08222024_120845.html 4  
1 form4-08222024_120845.xml 4 4155
  Complete submission text file 0001415889-24-021950.txt   5731
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Issuer) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O TRISALUS LIFE SCIENCES, INC. 6272 W. 91ST AVENUE WESTMINSTER CO 80031
Business Address
Martin George Kelly (Reporting) CIK: 0001982607 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39813 | Film No.: 241229932